Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens - Bochtler, Tilmann; Hegenbart, Ute; Granzow, Martin; Seckinger, Anja; Kimmich, Christoph; Goldschmidt, Hartmut; Ho, Anthony Dick; Hose, Dirk; Jauch, Anna; Schönland, Stefan (Journal of clinical oncology, 2015)
Gesehen am 07.07.2017